Summary
Chong He is a PhD-trained longevity scientist and translational leader with 11+ years in biotech and 15+ years of research experience applying protein and antibody engineering to aging and age-related diseases. He co-founded LiveBeyond to advise pharma, governments, clinics, and investors on gerotherapeutics, biomarkers, and clinical translation, and has driven biologics discovery through CMC and tech transfer at CDMOs. His work spans discovery to clinic—delivering multiple clinical candidates and integrating developability, Fc engineering, and analytical strategies to de-risk pipelines. A former Buck Institute postdoc, he led high-profile lifespan studies (including repurposing ibuprofen across model organisms) and builds platforms that blend lifespan assays with cell-cycle screens. Based in the San Francisco Bay Area, he combines deep wet-lab expertise with pragmatic commercial and regulatory insight, and quietly emphasizes rigorous due diligence over hype when evaluating longevity opportunities.
11 years of coding experience
4 years of employment as a software developer
Double B.S. Chemistry and Biology, Double B.S. Chemistry and Biology at Peking University
English, Chinese